Kelly Genevieve, Sweeney Cheryl M, Tobin Anne-Marie, Kirby Brian
Dermatology Research Group, Education and Research Centre, St. Vincent's University Hospital, Tallaght, Dublin, Ireland.
Int J Dermatol. 2014 Oct;53(10):1186-96. doi: 10.1111/ijd.12550. Epub 2014 Jun 25.
Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory disease of follicular occlusion characterized by boils, sinus tracts, fistulae, and scarring. It has a significant underestimated morbidity. Antimicrobial, immunosuppressive, anti-androgenic, and surgical approaches have been used with varying results. Knowledge of the pathogenesis of HS is fragmented, and treatment choices have hitherto been empiric without an exact understanding of the scientific basis for their use. Tumor necrosis factor-α inhibitors have shown promise in the treatment of HS in recent years, and the concept of HS as an immunological condition has come to the fore. The focus of this review is to discuss the immunological abnormalities underpinning HS as elucidated to date.
化脓性汗腺炎(HS)是一种以毛囊堵塞为特征的慢性复发性炎症性疾病,表现为疖肿、窦道、瘘管和瘢痕形成。其发病率被严重低估。抗菌、免疫抑制、抗雄激素和手术等治疗方法的效果各异。HS的发病机制尚不明确,迄今为止,治疗选择一直是经验性的,并未确切了解其使用的科学依据。近年来,肿瘤坏死因子-α抑制剂在HS治疗中显示出前景,HS作为一种免疫性疾病的概念也备受关注。本综述的重点是讨论迄今为止所阐明的HS潜在的免疫异常。